The fight against Tuberculosis (TB), a contagious disease primarily affecting the lungs, continues to evolve with advancements in diagnostic techniques. This article reviews the latest developments in TB detection, focusing on their efficacy and potential impact on patient outcomes.
Introduced in 2010, the GeneXpert MTB/RIF test revolutionized TB diagnostics. This molecular test identifies Mycobacterium tuberculosis and resistance to rifampicin in less than two hours. Its high sensitivity and specificity, even in smear-negative samples, make it a valuable tool in TB control, particularly in HIV co-infection and paediatric cases.
Line Probe Assays (LPAs) are another significant advancement. These molecular techniques detect specific genetic mutations associated with drug resistance. WHO has endorsed LPAs for the detection of multidrug-resistant TB (MDR-TB) due to their rapid turnaround time and high accuracy.
Next-Generation Sequencing (NGS) is a promising method for TB diagnosis. It allows comprehensive analysis of the entire Mycobacterium tuberculosis genome, providing information about drug resistance and genetic diversity. Although still in research phases, NGS has the potential to become a 'one-stop-shop' for TB diagnosis and drug susceptibility testing.
Advancements in imaging techniques, like the introduction of digital radiography and computer-aided detection, have improved the accuracy of TB diagnosis. These technologies offer better image quality and interpretation, aiding early detection and treatment initiation.
While smear microscopy and culture remain the backbone of TB diagnosis, these advancements offer faster, more accurate detection. They also provide insights into drug resistance, crucial for improving treatment strategies. As we continue to strive for TB elimination, embracing these innovative diagnostic approaches will be instrumental in achieving this goal.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation